Dr. Marco Bisoffi
- Office Location:
- Hashinger Science Center 211
- (714) 516-5961
- University of Basel, Ph.D. in Zoology
- Video Profile
Dr. Bisoffi was originally trained in molecular and cell biology, and in biochemistry as applied to projects concerned with the molecular characterization of the cuticle of nematode parasites of human medical importance at the Swiss Tropical Institute of the Faculty of Natural Sciences at the University of Basel in Basel, Switzerland. This phase of his career included academic stays at the Imperial College of Science, Technology and Medicine, Department of Biochemistry in London, UK, and at the International Institute of Genetics and Biophysics in Naples, Italy.
After graduation, Dr. Bisoffi changed his field of research to molecular cancer research and underwent further post-doctoral training in the Department of Biochemistry and Molecular Biology of the University of New Mexico Health Sciences Center in Albuquerque, New Mexico, USA, at the Institute of Medical Microbiology of the University of Basel in Basel, Switzerland, in the Gene Chip Laboratory at Hoffmann-La Roche in Basel, Switzerland, and in the Department of Clinical Research of the University of Bern in Bern, Switzerland. His research during this time of his career was concerned with the molecular profiling of breast tumor vasculature, molecular mechanisms of prostate cancer progression, and the molecular mechanisms of carcinogenesis in mast cell tumors.
In 2002, Dr. Bisoffi became a Faculty Member in the Department of Biochemistry and Molecular Biology of the University of New Mexico Health Sciences Center in Albuquerque, New Mexico, USA. In this capacity he established several research programs focused on the molecular mechanisms underlying prostate and breast cancer, the discovery and validation of biomarkers of early and progressive disease in these two type of hormone-dependent solid tumors, as well as the screening, identification, and testing of natural product based anti-prostate cancer organic small molecules and the elucidation of their mechanism of action. These projects were highly translational and included consented patient participation at the University of New Mexico Hospital and Cancer Center, and the Veterans Affairs Health Care System. Other projects included Dr. Bisoffi as an active collaborator in endeavors concerned with the development and use of targeted anti-prostate cancer nanoparticles and surface acoustic wave based pathogen biosensors.
In 2013, Dr. Bisoffi joined the Schmid College of Science and Technology at Chapman University as an Associate Professor of Biological Sciences, where he pursues some of the projects developed at the University of New Mexico (see Research Interests below).
- Molecular mechanisms underlying “field cancerization” in human tissues affected by adenocarcinomas
- Molecular mechanisms of prostate cancer progression to castration resistance
- Natural product based experimental therapeutics with a focus on reactive oxygen species and target protein degradation
- BIOL 209 (laboratory)
- Additional teaching assignments will follow
- American Association for Cancer Research
- American Society for Biochemistry and Molecular Biology
- Society for Basic Urologic Research
- Swiss Society for Cell Biology, Molecular Biology, and Genetics
Editorial and Review Boards
- Department of Defense Prostate Cancer Research Program
- Member of the Editorial Board for Journal of Cancer Research (Hindawi Publishing Corporation; Nasr City, Cairo, Egypt and New York, NY, USA).
- Reviewer for BioEssays, Cancers, Cancer Letters, Clinical Experimental Metastasis, Neoplasia, Bioorganic and Medicinal Chemistry Letters, PLoS, Journal of Cellular Biochemistry, Journal of Urology, and Biosensors and Bioelectronics
- Recent Creative, Scholarly Work and Publications
Fajardo AM, Mackenzie DA, Ji M, Deck LM, Jagt DL, Thompson TA, Bisoffi M. The curcumin analog ca27 down-regulates androgen receptor through an oxidative stress mediated mechanism in human prostate cancer cells. Prostate (2012), 72(6): 612-25.
Jones AC, Trujillo KA, Phillips GK, Fleet TM, Murton JK, Severns V, Shah SK, Davis MS, Smith AY, Griffith JK, Fischer EG, Bisoffi M. Early growth response 1 and fatty acid synthase expression is altered in tumor adjacent prostate tissue and indicates field cancerization. Prostate (2012), 72(11): 1159-70.
Trujillo KA, Jones AC, Griffith JK, Bisoffi M. Markers of field cancerization: Proposed clinical applications in prostate biopsies. Prostate Cancer (2012): 1-12.
Bisoffi M, Heaphy CM, Griffith JK. Field Cancerization in Mammary Tissues; in FIELD CANCERIZATION: BASIC SCIENCE AND CLINICAL APPLICATIONS (Dakubo GD, editor); NOVA Science Publishing, 2011. ISBN: 978-1-61761-386-9.